The mhGAP guideline has been developed to help countries improve their ability to address the increasing challenges of mental, neurological and substance use (MNS) conditions and reduce the treatment gap. This latest edition is the third iteration of the guideline and reflects years of investment in the mhGAP programme.

With a focus on narrowing the treatment gap, the revised recommendations are designed to ensure that mhGAP provides non-specialist health workers in low and middle-income countries with high-quality, timely, transparent, and evidence-based guidance to effectively treat and care for individuals with MNS conditions.

The need for improved capacity to address MNS conditions is growing, and the mhGAP guideline aims to assist countries in meeting this challenge. With 30 updated recommendations and 18 new ones, along with 90 existing ones, this latest edition includes a comprehensive set of guidelines that will help non-specialist health workers in low and middle-income countries provide effective care for individuals with MNS conditions.